Margetuximab Biosimilar - Onderzoeksgraad

[HER2]

2064

Human

This biosimilar is stable when stored at 2-8 degree C. For longer term storage (> 3 months) it is recommended to store this antibody at -20 degree C or -70 degree C.

Detects human HER2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Margetuximab.

[ERBB2; ERBB2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; HER2; MLN19; NEU; NGL; MLN 19]

[Margetuximab]

[receptor tyrosine-protein kinase erbB-2 isoform b; Receptor tyrosine-protein kinase erbB-2; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived on; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian); Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2]

54792098

NP_001005862.1

NM_001005862.1

P04626